Veracyte Debt to Equity Ratio 2012-2018 | VCYT

Current and historical debt to equity ratio values for Veracyte (VCYT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Veracyte debt/equity for the three months ending September 30, 2018 was 0.32.
Veracyte Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.03B $0.08B 0.32
2018-06-30 $0.03B $0.03B 0.98
2018-03-31 $0.03B $0.03B 0.84
2017-12-31 $0.03B $0.04B 0.68
2017-09-30 $0.03B $0.04B 0.59
2017-06-30 $0.03B $0.05B 0.53
2017-03-31 $0.03B $0.05B 0.48
2016-12-31 $0.03B $0.06B 0.43
2016-09-30 $0.03B $0.03B 0.83
2016-06-30 $0.03B $0.03B 0.73
2016-03-31 $0.02B $0.04B 0.57
2015-12-31 $0.01B $0.05B 0.10
2015-09-30 $0.01B $0.06B 0.09
2015-06-30 $0.01B $0.07B 0.08
2015-03-31 $0.01B $0.04B 0.14
2014-12-31 $0.01B $0.04B 0.12
2014-09-30 $0.00B $0.05B 0.07
2014-06-30 $0.00B $0.05B 0.09
2014-03-31 $0.00B $0.05B 0.09
2013-12-31 $0.01B $0.06B 0.09
2013-09-30 $0.01B $-0.08B -0.06
2013-06-30 $0.01B $-0.07B -0.07
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2011-12-31 $0.00B $-0.04B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.703B $0.072B
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $96.900B 22.58
Intuitive Surgical (ISRG) United States $61.300B 60.31
Edwards Lifesciences (EW) United States $35.181B 37.65
Fresenius Medical Care AG KGaA (FMS) Germany $21.436B 14.49
IDEXX Laboratories (IDXX) United States $17.360B 49.58
ABIOMED (ABMD) United States $15.139B 108.78
DexCom (DXCM) United States $13.400B 0.00
Hologic (HOLX) United States $12.863B 19.73
Teleflex (TFX) United States $11.842B 26.88
Varian Medical Systems (VAR) United States $11.433B 28.45
STERIS (STE) United Kingdom $9.523B 25.27
Masimo (MASI) United States $6.380B 41.37
Penumbra (PEN) United States $4.856B 293.19
LivaNova (LIVN) United Kingdom $4.430B 28.43
Globus Medical (GMED) United States $4.292B 26.90
Integra LifeSciences Holdings (IART) United States $3.916B 19.08
Wright Medical Group (WMGI) Netherlands $3.577B 0.00
Cantel Medical (CMD) United States $3.231B 31.87
Inogen (INGN) United States $3.117B 67.28
Integer Holdings (ITGR) United States $2.530B 21.17
Tandem Diabetes Care (TNDM) United States $2.433B 0.00
Glaukos (GKOS) United States $2.142B 0.00
Halyard Health (AVNS) United States $2.074B 18.68
OPKO Health (OPK) United States $2.060B 0.00
Nevro (NVRO) United States $1.381B 0.00
Luminex (LMNX) United States $1.175B 42.50
Natus Medical (BABY) United States $1.158B 24.33
Tactile Systems Technology (TCMD) United States $1.148B 182.76
Pacific Biosciences Of California (PACB) United States $1.094B 0.00
CryoLife (CRY) United States $1.045B 91.23
Orthofix (OFIX) United States $0.974B 28.12
Accelerate Diagnostics (AXDX) United States $0.913B 0.00
Intersect ENT (XENT) United States $0.892B 0.00
Mesa Laboratories (MLAB) United States $0.836B 49.43
AngioDynamics (ANGO) United States $0.778B 25.23
ViewRay (VRAY) United States $0.726B 0.00
AxoGen (AXGN) United States $0.620B 0.00
TransEnterix (TRXC) United States $0.571B 0.00
Si-Bone (SIBN) United States $0.486B 0.00
OrthoPediatrics (KIDS) United States $0.436B 0.00
Quotient (QTNT) Switzerland $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.381B 0.00
Sientra (SIEN) United States $0.353B 0.00
Fluidigm (FLDM) United States $0.352B 0.00
Accuray (ARAY) United States $0.344B 0.00
GenMark Diagnostics (GNMK) United States $0.336B 0.00
SeaSpine Holdings (SPNE) United States $0.272B 0.00
RTI Surgical (RTIX) United States $0.272B 42.80
IRadimed (IRMD) United States $0.259B 67.57
Nuvectra (NVTR) United States $0.251B 0.00
Neuronetics (STIM) United States $0.243B 0.00
Pulse Biosciences (PLSE) United States $0.242B 0.00
CRH Medical (CRHM) Canada $0.225B 38.75
Corindus Vascular Robotics (CVRS) United States $0.214B 0.00
Helius Medical Technologies (HSDT) United States $0.195B 0.00
T2 Biosystems (TTOO) United States $0.159B 0.00
Sensus Healthcare (SRTS) United States $0.130B 0.00
Ra Medical Systems (RMED) United States $0.105B 0.00
Ekso Bionics Holdings (EKSO) United States $0.103B 0.00
Apollo Endosurgery (APEN) United States $0.085B 0.00
EDAP TMS (EDAP) France $0.080B 0.00
Alphatec Holdings (ATEC) United States $0.071B 0.00
Biosig Technologies (BSGM) United States $0.070B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.065B 0.00
Second Sight Medical Products (EYES) United States $0.061B 0.00
Vermillion (VRML) United States $0.059B 0.00
Titan Medical (TMDI) Canada $0.053B 0.00
Electromed (ELMD) United States $0.042B 20.00
Restoration Robotics (HAIR) United States $0.041B 0.00
OBALON THERPTCS (OBLN) United States $0.039B 0.00
Viveve Medical (VIVE) United States $0.036B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
Xtant Medical Holdings (XTNT) United States $0.029B 0.00
Lianluo Smart (LLIT) China $0.026B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Microbot Medical (MBOT) United States $0.024B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.022B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
American Shared Hospital Services (AMS) United States $0.015B 11.22
Bioanalytical Systems (BASI) United States $0.014B 67.50
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Presbia (LENS) Ireland $0.009B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00